Venus Remedies to raise up to $30 million on preferential basis

20 May 2013 Evaluate

Venus Remedies has received an approval to raise funds by way of equity/convertible instruments in the company/its wholly owned subsidiary up to $30 million, on a preferential basis. The board of directors at its meeting held on May 18, 2013 has approved for the same. The above is however subject to approval of the shareholders, statutory approvals, applicable laws, guidelines and regulations.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

Venus Remedies Share Price

823.10 -2.70 (-0.33%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×